We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The European Medicines Agency has approved AstraZeneca’s Duaklir Genuair as a maintenance treatment for patients with chronic obstructive pulmonary disease. Read More